pyruvic acid and su 11248

pyruvic acid has been researched along with su 11248 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Devasahayam, N; Krishna, MC; Lizak, MJ; Matsumoto, S; Matsuo, M; Merkle, H; Mitchell, JB; Morris, HD; Munasinghe, JP; Saito, K; Suburamanian, S; Takakusagi, Y; Yasukawa, K	1

Other Studies

1 other study(ies) available for pyruvic acid and su 11248

Article	Year
In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization. Antioxidants & redox signaling, 2014, Sep-10, Volume: 21, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Contrast Media; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Female; Humans; Indoles; Magnetic Resonance Imaging; Mice, Inbred C3H; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Oxygen; Pyrroles; Pyruvic Acid; Sunitinib; Xenograft Model Antitumor Assays	2014

Article

Year

In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.

Antioxidants & redox signaling, 2014, Sep-10, Volume: 21, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Contrast Media; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Female; Humans; Indoles; Magnetic Resonance Imaging; Mice, Inbred C3H; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Oxygen; Pyrroles; Pyruvic Acid; Sunitinib; Xenograft Model Antitumor Assays

2014